Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP697673.RAYDcRLokLgt16269zart7nVVkbOHLF7iEYjb8uCqtavM130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697673.RAYDcRLokLgt16269zart7nVVkbOHLF7iEYjb8uCqtavM130_provenance.
• assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1112185.RAUUJlrqbfs2AVSbO1fxT3S97lT3O4bcjRXmPLmpQz69A130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1112185.RAUUJlrqbfs2AVSbO1fxT3S97lT3O4bcjRXmPLmpQz69A130_provenance.
• NP1112186.RAS6pPh3NeMrcMGLJs02nwTVOzOwss3G257-MpCENQXtI130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1112186.RAS6pPh3NeMrcMGLJs02nwTVOzOwss3G257-MpCENQXtI130_provenance.
• NP1112189.RAbhRWfZoqdJvClGIxMOeLQLISfv_E0Z0LU-FBwN8CfSc130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1112189.RAbhRWfZoqdJvClGIxMOeLQLISfv_E0Z0LU-FBwN8CfSc130_provenance.
• NP1112190.RAZpHksYD44T-AIILcWa5Qr563stgGXPro7OYCHytNJgM130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1112190.RAZpHksYD44T-AIILcWa5Qr563stgGXPro7OYCHytNJgM130_provenance.
• NP1112191.RASR-QASQicdwR5XBPdxIncHCM_weeTm8RBvkd13DfOUc130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1112191.RASR-QASQicdwR5XBPdxIncHCM_weeTm8RBvkd13DfOUc130_provenance.
• NP952611.RAAz3-5TElAmvJHlXg3AzgMoCqLNKjg5JmwObHKSsY5lQ130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952611.RAAz3-5TElAmvJHlXg3AzgMoCqLNKjg5JmwObHKSsY5lQ130_provenance.
• NP952831.RAhozByJl9C4seG5_nrd5x-y_X1jUR4zpCYoxJxnhInvA130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952831.RAhozByJl9C4seG5_nrd5x-y_X1jUR4zpCYoxJxnhInvA130_provenance.
• NP752006.RAD5o_nrJQFvaUu3FBnnLXtr-iafx3RzfH6jooUI4OFJY130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752006.RAD5o_nrJQFvaUu3FBnnLXtr-iafx3RzfH6jooUI4OFJY130_provenance.
• assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1112184.RApbAzldz0ZfDgzE-r7F1gH3xeuf8Juj-MKT1kXln8f4Q130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1112184.RApbAzldz0ZfDgzE-r7F1gH3xeuf8Juj-MKT1kXln8f4Q130_provenance.
• NP1112187.RAtCFz60SWWzHHyuhvXAtTrmR0Ej0sGai06EtKvDSfRRk130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1112187.RAtCFz60SWWzHHyuhvXAtTrmR0Ej0sGai06EtKvDSfRRk130_provenance.
• NP755539.RAIVhRZTAdz7rzWsteh_g5EYbSR2hAo-vLJeFBXw8A5kw130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755539.RAIVhRZTAdz7rzWsteh_g5EYbSR2hAo-vLJeFBXw8A5kw130_provenance.
• NP755769.RAIP18QeA2kdhAS-WW6qYXv2C6G_d-jLBmmkPhOlu2otg130_assertion description "[Doxorubicin strongly induces p53 and p73 binding to the NIS promoter, leading to an increased expression of endogenous NIS mRNA and protein in HCC and CCA cells, but not in PHH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755769.RAIP18QeA2kdhAS-WW6qYXv2C6G_d-jLBmmkPhOlu2otg130_provenance.